GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

• Last SEC data release: 2024-12-31
• Last 15 days FTD volume: NZ$47.62 M
• Last 3 months FTD volume: NZ$96.61 M
• Last year FTD volume: NZ$96.61 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
AstraZeneca AZN	NZ$53.97 M	NZ$0.19 B	🇬🇧 UK
Pfizer PFE	NZ$37.96 M	NZ$0.35 B	🇺🇸 USA
Merck MRK	NZ$76.67 M	NZ$0.12 B	🇺🇸 USA
Novartis NVS	NZ$80.83 M	NZ$0.14 B	🇨🇭 Switzerland
Sanofi SNY	NZ$4.14 M	NZ$72.79 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	NZ$12.16 M	NZ$36.72 M	🇮🇱 Israel
Dynavax Technologies DVAX	NZ$0.67 M	NZ$32.36 M	🇺🇸 USA